John Erb has 35 years of experience in the medical device industry.
John is currently Chairman of the Board of Vascular Solutions, Inc., a NASDAQ listed company and has served on this board for 8 years. Vascular Solutions manufactures medical devices for the cardiology and interventional radiology markets and has annual revenue of approximately US$100 million.
John previously served 8 years on the Board of Directors of CryoCath Technologies, Inc., a public company listed on the Toronto stock exchange. CryoCath Technologies developed, manufactured and distributed products to the electrophysiology cardiologist for the treatment of atrial fibrillation. CryoCath Technologies was acquired by Medtronic for US$350 million in 2008. John also served 8 years on the Board of Directors of SenoRx, Inc., a NASDAQ listed company. SenoRx developed, manufactured and distributed products used by oncologists treating breast cancer. SenoRx was acquired by C. R. Bard for US$250 million in 2010.
In 2007, John was Executive Chairman of the Board for CHF Solutions, Inc., a medical device company involved in the treatment of congestive heart failure. From 2001 to 2006, John was Chief Executive Officer of CHF Solutions. CHF Solutions was acquired by Gambro in 2010. From 1997 to 2001, John was President and Chief Executive Officer of IntraTherapeutics, Inc., a medical device company involved in the development, manufacturing, and distribution of peripheral vascular stents. IntraTherapeutics was acquired by Sulzer Medica for US$150 million in 2001. Previously, John was Vice President of Operations for Schneider Worldwide, a division of Pfizer, Inc. John spent 10 years with Johnson & Johnson's Iolab Division and started his career with American Hospital Supply Corporation.
John is currently on the Board of Directors of Jan Medical, a venture capital finance start-up focused on stroke. John has a bachelor's degree in business administration from California State University, Fullerton. John currently is the Chairman and Chief Executive Officer of Cardia Access, Inc., a start-up medical device company focused on innovative technologies for pacing the heart.